Lipsitch was a co-founder of the Cambridge Working Group in 2014, whose efforts helped to initiate a pause in US government funding for research involving the creation of potential pandemic pathogens, such as transmission-enhanced avian influenza strains. Lipsitch has been featured in thousands of press articles and media interviews from CNN and BBC, to the Guardian and Wall Street Journal, and writes in and is interviewed regularly for outlets such as The New York Times and The Washington Post on COVID-19.Īdditionally, Dr.
This includes real-time estimation of SARS transmissibility and modeling of control measures, and calculating the reproductive number for the 1918 “Spanish flu” and severity of the 2009 H1N1 flu pandemic, which has informed non-pharmaceutical interventions such as physical distancing. His recent COVID-19 research builds on 20 years of groundbreaking work on SARS, pandemic influenza, and other emerging infections, as well as on the seasonality of influenza and coronavirus disease, which has contributed to the foundation for modern pandemic response. His research informs the use of transmission-dynamic simulations to improve the design of randomized and observational studies of infectious disease interventions, and bioethics related to infectious diseases and clinical trials in emergencies. Lipsitch is an author of more than 350 peer-reviewed publications on antimicrobial resistance, epidemiologic methods, mathematical modeling of infectious disease transmission, bacterial and human population genetics, immunity to Streptococcus pneumoniae, and COVID-19 epidemiology. He is an internationally-recognized expert in methods and disease transmission modeling, and has been a leading scientific authority during the COVID-19 pandemic.ĭr. Marc Lipsitch is Professor of Epidemiology and Director of the Center for Communicable Disease Dynamics at the Harvard T.H.
0 kommentar(er)
